Introduction
Tumor Treating Fields (TTFields) is a non-invasive therapy that utilizes intermediate-frequency alternating electric fields to disrupt cancer cell division. While it has shown success in treating stationary targets like brain tumors, its application to lung cancer is complicated by respiratory motion. As a patient breathes, the lungs change shape and their electrical conductivity shifts, causing the electric field (EF) intensity within the tumor to fluctuate and often drop below therapeutic levels.
Traditional static treatments fail to account for these dynamic changes. Current solutions, such as respiratory gating, are often invasive or too slow for real-time adjustments. This paper proposes a novel closed-loop system that uses real-time Electrical Impedance Tomography (EIT) to guide TTFields, ensuring a consistent therapeutic dose throughout the respiratory cycle.
Methods: A Closed-Loop Strategy
The researchers developed a closed-loop TTFields strategy that integrates real-time monitoring with dynamic optimization. The system consists of three primary components:
- Real-time Monitoring via EIT: Electrical Impedance Tomography uses surface electrodes to measure internal conductivity changes. This allows the system to track the respiratory phase in real-time without invasive sensors.
- Dynamic Optimization: Using the 4D Lung Imaging of NSCLC Patients (4D-Lung) dataset, the authors constructed high-fidelity biomechanical models of lung deformation. They pre-computed "leadfield matrices" for 10 distinct phases of the respiratory cycle to map electrode currents to internal EF intensities.
- Adaptive Control: As EIT detects shifts in the breathing phase, the system instantly adjusts electrode parameters to maintain the optimal electric field focus on the tumor.
A key innovation is the dual-use of the electrode array: the same hardware is used for both EIT sensing and TTFields delivery, significantly reducing the device's bulk for the patient who may need to wear it for up to 20 hours a day.
Key Results and Insights
The study highlights a significant "conductivity gap" in traditional treatments. Without adaptation, the average EF intensity in the tumor drops by approximately 20% (from 1.08 V/cm to 0.87 V/cm) as the lungs fill with air during inhalation.
The proposed closed-loop method demonstrated superior performance in simulations:
- Consistency: The system maintained a steady average EF strength of 1.30 V/cm across all respiratory stages at a standard dose, significantly outperforming traditional static approaches.
- Efficiency: To achieve a standard 1.0 V/cm field, the closed-loop system required 23.10% less total current (1338 mA vs. 2400 mA) compared to traditional methods. This reduction is critical as it could minimize skin irritation, the most common side effect of TTFields.
- Real-time Capability: EIT image reconstruction was achieved in just 0.037 seconds, proving the system's readiness for real-time clinical application.
Limitations and Future Directions
While promising, the current simulation relies on a simplified lung geometric model that does not yet account for outer chest contour movement or cardiac-induced deformation. Future iterations could integrate EKG monitoring to refine the field further. Additionally, clinical validation is required to confirm these computational findings in human patients, particularly regarding practical effectiveness and thermal safety on the skin.
Summary updated